Fragile X-Syndrome Market size is expected to grow at a CAGR of 5.43% during the forecast period and the market size is expected to reach nearly US$ 176.13 Mn. by 2029. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.To know about the Research Methodology :- Request Free Sample Report
Fragile X-Syndrome Market Definition:
Fragile X Syndrome is the most frequent genetic disorder and the syndrome is diagnosed by DNA- blood testing.Global Fragile X-Syndrome Market Dynamics:
The development in the counselling centers and their presence at the state level are still ongoing for the parents and relatives to prevent the recurrence of fragile X syndrome in the family. Counselling is preferred to be the best treatment for fragile X syndrome which cures the disease by 48%. The increased incidences of males as compared to females and the repetition of the disease from one generation to the next increase the number of patients having this and many other genetic disorders drive the global market. There may be the possibilities of detection of fragile X population and from ethnic groups. The studies give prevalence that fragile X syndrome is 0.5 to 3% of mentally retarded males and the higher prevalence of 11% is observed in the year 2022. In the case of women, 1 from 260 is detected with fragile X syndrome. The new emerging research organization in the market are equipped with and utilizes the expertise of professionals in various clinical disciplines led to give important advances in the understanding of fragile x-related disorders and treatment. The development of a simple scoring system to select individuals for fragile X syndrome testing is likely boosting the global market. Nowadays PCR tests are applied for the detection of diseases with genetic instability helps in the detection of the disease and diagnosis for the same.Fragile X-Syndrome Market Segment Analysis:
The report groups the Global Fragile X-Syndrome Market in different segments By Product, End User, and Region to forecast the revenues and analyze the market share of each segment over the forecast period. Based on Product, the Global Fragile X-Syndromes Market is segmented into ACT-01, AMO-01, ANAVEX-273, and AUT-00206. Based on End User, the Global Fragile X-Syndromes Market segmented into clinics, hospitals, and research centers. Research Centers Segment was dominant in 2022 and is expected to command a market share of 5.43% by 2029. To improve the diagnosis and treatment of Fragile X syndrome and its related conditions, the Centers for Collaborative Research are conducting the research program for syndrome detection and diagnosis. These centers are geared toward stimulating multidisciplinary, multi-institutional research on genetic disorders. The National Institute of Chronic Hereditary Disorders is one and many other intramural and extramural organizations that supports and conducts a broad range of research on Fragile X syndrome. Many researchers are studying fragile X-associated disorders having main focus is to find out the fragile X-associated primary ovarian insufficiency and fragile X-associated tremor syndrome. The NICHD-supported research groups are seeking ways to better diagnose and screen newborns for Fragile X mutations and permutations. There are many new arrivals of technological designs that are applied to detect fragile X alleles and other gene mutations. There are many programs conducted by many government and non-government organizations on genetic disorders to gain awareness among the global population. FRAXA research foundation is a research organization that makes a detailed study on the fragile X-Syndrome. The research group has invested US $ 30, 692, 922 on the fragile X syndrome. These kinds of activities by the research centers drive the global fragile X-syndrome market.Fragile X-Syndrome Market Regional Insights:
North America is expected to command the largest market share of 5.43% by 2029 All guideline committee and American College of Medical Genetics (ACMG) professionals assist healthcare professionals in making decisions regarding genetic diagnosis and testing. Laboratory infrastructure and early intervention services help peoples learn important skills. Therapy and medicines are also available to controls the gene mutations and their effects on the other disorders. Local public school systems and provide services and support for children age 3 years and older and those also suffering from genetic disorders. The help centers help fragile X syndrome disorder families helps learn how and where to have their children evaluated and how to find services. The objective of the report is to present a comprehensive analysis of the Global Fragile X-Syndrome Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Fragile X-Syndrome Market dynamics, structure by analyzing the market segments and projects the Global Fragile X-Syndrome Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Fragile X-Syndrome Market make the report investor’s guide.Fragile X-Syndrome Market Report Scope: Inquire before buying
Fragile X-Syndrome Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 121.65 Mn. Forecast Period 2023 to 2029 CAGR: 5.43% Market Size in 2029: US $ 176.13 Mn. Segments Covered: by Product Type ACT-01 AMO-01 ANAVEX-273 AUT-00206 by End User Clinics Hospitals Research Centers Fragile X-Syndrome Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Fragile X-Syndrome Market Key Players
1. Anavex Life Sciences Corp. 2. Ovid Therapeutics 3. Neuren Pharmaceuticals 4. Eli Lilly and Company 5. Bellus Health Inc. 6. AMO Pharma 7. Marinus Pharmaceuticals Inc. 8. Karus Therapeutics. SA 9. Zynerba Pharmaceuticals, Inc. 10.Lupin Pharmaceuticals 11.Zydus Candila 12.Sun Pharma Frequently Asked Questions: 1. Which region has the largest share in Global Fragile X-Syndrome Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Fragile X-Syndrome Market? Ans: The Global Fragile X-Syndrome Market is growing at a CAGR of 5.43% during forecasting period 2023-2029. 3. What is scope of the Global Fragile X-Syndrome Market report? Ans: Global Fragile X-Syndrome Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Fragile X-Syndrome Market? Ans: The important key players in the Global Fragile X-Syndrome Market are – Anavex Life Sciences Corp., Ovid Therapeutics, Neuren Pharmaceuticals, Eli Lilly and Company, Bellus Health Inc., AMO Pharma, Marinus Pharmaceuticals Inc., Karus Therapeutics. SA, Zynerba Pharmaceuticals, Inc., Lupin Pharmaceuticals, Zydus Candila, and Sun Pharma 5. What is the study period of this Market? Ans: The Global Fragile X-Syndrome Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Fragile X-Syndromes Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Fragile X-Syndrome Market 3.4. Geographical Snapshot of the Fragile X-Syndrome Market, By Manufacturer share 4. Global Fragile X-Syndromes Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Fragile X-Syndromes Market 5. Supply Side and Demand Side Indicators 6. Global Fragile X-Syndromes Market Analysis and Forecast, 2022-2029 6.1. Global Fragile X-Syndromes Market Size & Y-o-Y Growth Analysis. 7. Global Fragile X-Syndromes Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 7.1.1. ACT-01 7.1.2. AMO-01 7.1.3. ANAVEX-273 7.1.4. AUT-00206 7.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 7.2.1. Clinics 7.2.2. Hospitals 7.2.3. Research Centers 8. Global Fragile X-Syndromes Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 9.1.1. ACT-01 9.1.2. AMO-01 9.1.3. ANAVEX-273 9.1.4. AUT-00206 9.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 9.2.1. Clinics 9.2.2. Hospitals 9.2.3. Research Centers 10. North America Fragile X-Syndrome Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 12. Canada Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 13. Mexico Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 14. Europe Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 15. Europe Fragile X-Syndrome Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 17. France Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 18. Germany Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 19. Italy Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 20. Spain Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 21. Sweden Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 22. CIS Countries Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 23. Rest of Europe Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 24. Asia Pacific Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 25. Asia Pacific Fragile X-Syndrome Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 27. India Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 28. Japan Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 29. South Korea Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 30. Australia Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 31. ASEAN Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 32. Rest of Asia Pacific Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 33. Middle East Africa Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 34. Middle East Africa Fragile X-Syndrome Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 36. GCC Countries Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 37. Egypt Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 38. Nigeria Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 39. Rest of ME&A Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 40. South America Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 41. South America Fragile X-Syndrome Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 43. Argentina Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 44. Rest of South America Fragile X-Syndrome Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Fragile X-Syndromes Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Anavex Life Sciences Corp. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Ovid Therapeutics 45.3.3. Neuren Pharmaceuticals 45.3.4. Eli Lilly and Company 45.3.5. Bellus Health Inc. 45.3.6. AMO Pharma 45.3.7. Marinus Pharmaceuticals Inc. 45.3.8. Karus Therapeutics. SA 45.3.9. Zynerba Pharmaceuticals, Inc. 45.3.10. Lupin Pharmaceuticals 45.3.11. Zydus Candila 45.3.12. Sun Pharma 46. Primary Key Insights